Monitoring hemodynamic changes during anesthesia induction
Hemodynamic Effects of Anesthesia Induction
Kliniken Essen-Mitte · NCT06421181
This study is testing if using two different monitoring devices during anesthesia can help doctors better understand heart changes and improve safety for patients undergoing high-risk surgeries.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Kliniken Essen-Mitte (other) |
| Locations | 1 site (Essen, North Rhine-Westphalia) |
| Trial ID | NCT06421181 on ClinicalTrials.gov |
What this trial studies
This project aims to characterize the hemodynamic changes that occur during the induction of anesthesia using two complementary monitoring devices. One device provides continuous monitoring with real-time data, while the other utilizes point-of-care ultrasound/echocardiography for detailed diagnostics. The study will explore the potential of implementing advanced echocardiography in a point-of-care setting during anesthesia induction and evaluate the effectiveness of this approach by comparing analyses conducted by non-certified anesthetists with those performed by certified experts. The goal is to enhance hemodynamic profiling and improve patient outcomes during high-risk surgical procedures.
Who should consider this trial
Good fit: Ideal candidates are patients undergoing elective laparotomy who require arterial and central-venous lines due to the invasiveness of the surgery.
Not a fit: Patients under 18 years old, those with severe cardiovascular conditions, or those unwilling to consent to data sharing may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved hemodynamic management during anesthesia induction, potentially reducing postoperative complications and mortality.
How similar studies have performed: Previous studies have shown that hemodynamic monitoring can reduce postoperative complications, suggesting that this approach may yield beneficial results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing elective laparotomy in the hospital Evangelische Kliniken Essen-Mitte * Due to the invasiveness of the planned surgery there is an indication for an arterial and central-venous line as well as an peridural catheter Exclusion Criteria: * Age \< 18 years * Lack of written informed consent * Insufficient language skills * Unwillingness to have pseudonymized disease data stored at the study site and lack of consent to share anonymized data as part of the clinical trial * American society of anaesthesiologists physical status higher as grade 3 * congestive heart failure with a grade of 2 or higher according to the New York heart association (NYHA) * Ischemic cardiopathy with a grade of 2 or higher according to the Canadian cardiovascular society (CCS) * Known severe valve pathologies of the heart * Chronic kidney disease with dependency of hemodialysis * Atrial fibrillation ora trail flutter * Pulmonary hypertension
Where this trial is running
Essen, North Rhine-Westphalia
- Evangelische Kliniken Essen-Mitte — Essen, North Rhine-Westphalia, Germany (RECRUITING)
Study contacts
- Principal investigator: Aarne Feldheiser, M.D., PhD. — Evangelische Kliniken Essen-Mitte
- Study coordinator: Aarne Feldheiser, M.D., PhD.
- Email: a.feldheiser@kem-med.com
- Phone: +49201174
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Patients Undergoing Anaesthesia Induction, Hemodynamic monitoring, Point-of-care ultrasound, Point-of-care echocardiography, Anaesthesia induction, Respiratory effects